Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) in a research report released on Thursday morning. The firm issued a hold rating on the stock. Several other research firms also recently weighed in on IONS. Sanford C. Bernstein initiated coverage on shares of Ionis Pharmaceuticals in a research note on Tuesday, […]
MQS Management LLC acquired a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,547 shares of the company’s stock, valued at approximately $247,000. A number of other institutional investors and hedge […]
First Trust Advisors LP trimmed its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 14.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,780,933 shares of the company’s stock after selling 296,327 shares during the quarter. […]
First Trust Advisors LP lowered its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 14.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,780,933 shares of the company’s stock after selling 296,327 shares during the period. […]
Tweedy Browne Co LLC raised its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 30.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,541,136 shares of the company’s stock after buying an additional 818,148 shares during the quarter. Ionis Pharmaceuticals accounts for […]